Verónica Alonso

930 total citations
32 papers, 516 citations indexed

About

Verónica Alonso is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Verónica Alonso has authored 32 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Verónica Alonso's work include Bone health and treatments (11 papers), Bone Metabolism and Diseases (8 papers) and Prostate Cancer Treatment and Research (6 papers). Verónica Alonso is often cited by papers focused on Bone health and treatments (11 papers), Bone Metabolism and Diseases (8 papers) and Prostate Cancer Treatment and Research (6 papers). Verónica Alonso collaborates with scholars based in Spain, United States and Mexico. Verónica Alonso's co-authors include Juan A. Ardura, Arancha R. Gortázar, Peter A. Friedman, Pedro Esbrit, M. V. Alvarez-Arroyo, Gorjana Rackov, María M. Escribese, Elena Izquierdo, Francisco C. Pérez‐Martínez and Bin Wang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Verónica Alonso

28 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verónica Alonso Spain 13 307 201 63 59 49 32 516
Brian T. Zafonte United States 10 325 1.1× 125 0.6× 46 0.7× 37 0.6× 56 1.1× 13 538
Delphine Goehrig France 13 362 1.2× 284 1.4× 68 1.1× 132 2.2× 58 1.2× 20 697
Sarah C. Moser Netherlands 5 320 1.0× 288 1.4× 48 0.8× 50 0.8× 35 0.7× 7 548
Guojun Qu China 6 356 1.2× 216 1.1× 38 0.6× 113 1.9× 42 0.9× 7 521
Yaxing Zhou China 10 273 0.9× 83 0.4× 85 1.3× 67 1.1× 46 0.9× 17 572
Lucy Phillips United States 15 303 1.0× 118 0.6× 53 0.8× 79 1.3× 165 3.4× 23 768
Joachim Theilhaber United States 11 406 1.3× 154 0.8× 17 0.3× 84 1.4× 66 1.3× 18 634
Wengui Shi China 14 350 1.1× 111 0.6× 37 0.6× 29 0.5× 113 2.3× 32 619
Céline Chipoy France 6 327 1.1× 171 0.9× 46 0.7× 81 1.4× 35 0.7× 7 448
Joel A. Yates United States 15 310 1.0× 112 0.6× 111 1.8× 84 1.4× 34 0.7× 28 601

Countries citing papers authored by Verónica Alonso

Since Specialization
Citations

This map shows the geographic impact of Verónica Alonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verónica Alonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verónica Alonso more than expected).

Fields of papers citing papers by Verónica Alonso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verónica Alonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verónica Alonso. The network helps show where Verónica Alonso may publish in the future.

Co-authorship network of co-authors of Verónica Alonso

This figure shows the co-authorship network connecting the top 25 collaborators of Verónica Alonso. A scholar is included among the top collaborators of Verónica Alonso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verónica Alonso. Verónica Alonso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tirado‐Cabrera, Irene, et al.. (2025). CAV-1 regulates osteocyte communication with osteoclast and osteoblast precursors. Scientific Reports. 15(1). 24576–24576.
3.
Ardura, Juan A., et al.. (2020). Role of Calcium Signaling in Prostate Cancer Progression: Effects on Cancer Hallmarks and Bone Metastatic Mechanisms. Cancers. 12(5). 1071–1071. 51 indexed citations
4.
Ardura, Juan A., et al.. (2020). MINDIN secretion by prostate tumors induces premetastatic changes in bone via β-catenin. Endocrine Related Cancer. 27(7). 441–456. 4 indexed citations
5.
Tirado‐Cabrera, Irene, et al.. (2020). Primary cilia mediate parathyroid hormone receptor type 1 osteogenic actions in osteocytes and osteoblasts via Gli activation. Journal of Cellular Physiology. 235(10). 7356–7369. 21 indexed citations
6.
Ardura, Juan A., Sergio Portal‐Núñez, Verónica Alonso, Beatriz Bravo, & Arancha R. Gortázar. (2019). Handling Parathormone Receptor Type 1 in Skeletal Diseases: Realities and Expectations of Abaloparatide. Trends in Endocrinology and Metabolism. 30(10). 756–766. 14 indexed citations
7.
Ardura, Juan A., Gorjana Rackov, Elena Izquierdo, et al.. (2019). Targeting Macrophages: Friends or Foes in Disease?. Frontiers in Pharmacology. 10. 1255–1255. 84 indexed citations
9.
Ardura, Juan A., Verónica Alonso, Pedro Esbrit, & Peter A. Friedman. (2016). Oxidation inhibits PTH receptor signaling and trafficking. Biochemical and Biophysical Research Communications. 482(4). 1019–1024. 10 indexed citations
10.
López‐Martín, Estrella, Rachel Thompson, Sabina Gainotti, et al.. (2016). Overview of existing initiatives to develop and improve access and data sharing in rare disease registries and biobanks worldwide. Expert Opinion on Orphan Drugs. 4(7). 729–739. 4 indexed citations
11.
Liu, Li, Verónica Alonso, Lida Guo, et al.. (2012). Na+/H+ Exchanger Regulatory Factor 1 (NHERF1) Directly Regulates Osteogenesis. Journal of Biological Chemistry. 287(52). 43312–43321. 25 indexed citations
12.
Martí, Nuria, et al.. (2010). Toxina Botulínica A en el tratamiento de la hiperhidrosis primaria: estudio prospectivo de 52 pacientes. Actas Dermo-Sifiliográficas. 101(7). 614–621. 5 indexed citations
13.
Alonso, Verónica, et al.. (2009). Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells. Life Sciences. 85(11-12). 421–430. 9 indexed citations
14.
Alonso, Verónica, et al.. (2008). Parathyroid hormone‐related protein (107–139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor‐2. Journal of Cellular Physiology. 217(3). 717–727. 47 indexed citations
15.
Monteagudo, Carlos, et al.. (2006). Siringoma condroide: revisión clínica e histológica de ocho casos. Actas Dermo-Sifiliográficas. 97(9). 573–577. 10 indexed citations
17.
Gortázar, Arancha R., Verónica Alonso, M. V. Alvarez-Arroyo, & Pedro Esbrit. (2006). Transient Exposure to PTHrP (107-139) Exerts Anabolic Effects through Vascular Endothelial Growth Factor Receptor 2 in Human Osteoblastic Cells In Vitro. Calcified Tissue International. 79(5). 360–369. 48 indexed citations
18.
Banzo, J., et al.. (2005). Atlas de gammagrafía de receptores de somatostatina en tumores neuroendocrinos de páncreas y tumores carcinoides. Revista Española de Medicina Nuclear. 24(4). 278–292. 5 indexed citations
19.
Banzo, J., et al.. (2004). Tumor carcinoide y metástasis óseas: Diagnóstico mediante gammagrafía de receptores de somatostatina. Revista Española de Medicina Nuclear. 23(6). 394–402. 6 indexed citations
20.
Banzo, J., et al.. (2003). Gammagrafía de receptores de somatostatina. ¿Cuándo hacer una SPECT?. Revista Española de Medicina Nuclear. 22(2). 68–75. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026